Hangzhou Thinheal Pharma-Tech Co.,Ltd

With over 20 years of experience in the peptide industry, we offer integrated capabilities spanning R&D, pilot-scale development, and cGMP-compliant production, with an annual capacity ranging from milligrams to 4,000 kilograms. Leveraging both solid-phase and liquid-phase peptide synthesis technologies, we provide one-stop API and CRDMO solutions, all backed by comprehensive cGMP and ISO quality assurance systems.

Hangzhou Thinheal Pharma-Tech Co.,Ltd is listed as a CDMO in the peptide supply chain, serving Asia markets from China (Hangzhou). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 3 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.